PRGO — PERRIGO Co plc
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1585364 ·
Last close
$15.42
Market Cap
$2.13B
52W High
$21.16
52W Low
$8.81
ADV30
2,752,197
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,022,800,000 | 313,900,000 | 39,000,000 | 74,500,000 | 7,609,500,000 | 399,700,000 | 5,093,700,000 |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 1,109,600,000 | 362,200,000 | 84,400,000 | -1,418,100,000 | 8,535,200,000 | 531,600,000 | 5,599,700,000 |
| Sep 2025 | 1,043,300,000 | 377,100,000 | 93,400,000 | 7,500,000 | 10,084,000,000 | 432,100,000 | 5,637,500,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$189,200,000
Investing CF
$-62,100,000
Financing CF
$-204,100,000
CapEx
$-81,700,000
Dividends Paid
$-158,600,000
Buybacks
—
EPS Diluted TTM
$-13.10
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-4,001,900,000
Inventory
$1,064,500,000
Receivables
$709,900,000
ST Investments
—
EBIT TTM
$-1,449,300,000
Pretax Income TTM
$-1,612,400,000
Interest Exp TTM
$163,100,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,144,900,096
EBITDA
$615,500,032
Free Cash Flow
$437,212,512
Enterprise Value
$4,972,288,000
Total Cash
$399,700,000
Total Debt
$3,476,400,128
Shares Out
138,367,770
Trailing EPS
$-12.29
Book Value
$18.14
ROE
-48.7%
ROA
2.0%
Div Yield
8.49%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,253,100,000 | 312,800,000 | -1,425,400,000 | 8,535,200,000 | 5,599,700,000 | 2,935,500,000 | 238,500,000 |
| Dec 2024 | 4,373,400,000 | 311,900,000 | -171,800,000 | 9,647,700,000 | 5,328,300,000 | 4,319,400,000 | 362,900,000 |
| Dec 2023 | 4,655,600,000 | 284,100,000 | -12,700,000 | 10,809,100,000 | 6,041,200,000 | 4,767,900,000 | 405,500,000 |
| Dec 2022 | 4,451,600,000 | 121,400,000 | -140,600,000 | 11,017,300,000 | 6,175,200,000 | 4,842,100,000 | 307,300,000 |
TTM Snapshot
Revenues TTM
$4,355,400,000
NetIncome TTM
$-62,600,000
OpCashFlow TTM
$0
Assets (Latest)
$8,535,200,000
Forward EPS
$2.40
Max Pain — expiry 2026-10-16
max pain strike: $15.00 · spot: $14.93 · call oi: 5,809 · put oi: 223
Expected Move to 2026-10-16:
±$1.90
(12.73%) —
implied range
$13.03 –
$16.83
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BHC | Bausch Health Companies Inc. | $2.13B | $5.69 | — |
| OCUL | OCULAR THERAPEUTIX, INC | $2.12B | $9.65 | — |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.19B | $16.44 | — |
| PBH | Prestige Consumer Healthcare Inc. | $2.21B | $46.61 | — |
| TRVI | Trevi Therapeutics, Inc. | $2.05B | $14.41 | — |
News headlines (Yahoo Finance, 1h cache)
Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
2026-09-25 10:34 · Yahoo
Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?
2026-09-04 15:30 · Yahoo
Perrigo to Attend the Barclays Global Consumer Conference
2026-08-27 12:30 · Yahoo
PRGO or NEOG: Which Is the Better Value Stock Right Now?
2026-08-26 15:40 · Yahoo
Perrigo (PRGO) Q2 2026 Earnings Call Transcript
2026-08-12 13:59 · Yahoo
Perrigo (PRGO) In Focus As Q2 Earnings Beat Revives The Undervalued Narrative
2026-08-08 11:10 · Yahoo
Perrigo (PRGO) Surpasses Q2 Earnings and Revenue Estimates
2026-08-05 11:45 · Yahoo
This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
2026-08-22 21:35 · Yahoo
Perrigo Company plc Q2 2026 Earnings Call Summary
2026-08-05 22:45 · Yahoo
Should Value Investors Buy Perrigo (PRGO) Stock?
2026-08-26 13:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.